<DOC>
	<DOCNO>NCT00515619</DOCNO>
	<brief_summary>The main purpose trial determine safety efficacy Lacosamide long term therapy .</brief_summary>
	<brief_title>Assess Safety Efficacy Lacosamide Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>diagnosis Epilepsy completion double blind trial take investigational drug Lacosamide meeting withdrawal criterion double blind trial</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>